home / stock / ctlt / ctlt articles

CTLT Articles, Catalent Inc.

Stock Information
Company Name: Catalent Inc.
Stock Symbol: CTLT
Market: NYSE
Website: catalent.com
Menu
CTLT CTLT Quote CTLT Short CTLT News CTLT Articles CTLT Message Board
Get CTLT Alerts

News, Short Squeeze, Breakout and More Instantly...
Sarepta's Expanded Approval Unlikely To Influence Novo Holdings' Acquisition of Catalent, But Provides Investor Protection Amid Uncertainty | Benzinga

Shares of Catalent Inc (NYSE:CTLT), which manufactures Elevidys, are trading higher with a strong session volume of 3.6 million compared to an aver...
Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition | Benzinga

Novo Nordisk A/S (NYSE:NVO) is witnessing a surge in the number of patients starting on its weight-loss drug, Wegovy, in the U.S. This increase com...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HCP, NXPL, CTLT | Benzinga

NEW YORK, April 26, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potenti...

Robbins LLP is Investigating the Acquisition of Catalent, Inc. (CTLT) by Novo Holdings | Benzinga

SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP informs investors it is investigating the acquisition of C...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLT, SCX, EVBG, NS | Benzinga

NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potenti...

Kuehn Law Encourages NGM, CTLT, SDPI, and HRT Investors to Contact Law Firm | Benzinga

NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to th...

Novo Nordisk Sets Timeframe For Its Next-Gen Experimental Obesity Drug | Benzinga

Novo Nordisk A/S’s (NYSE:NVO) head of development, Martin Holst Lange, expressed strong confidence in the drugmaker’s ability...
Escalating Demand for Obesity Drugs Creates Time-Sensitive Race for Eli Lilly, Novo Nordisk | Benzinga

Eli Lilly (NYSE:LLY) is aggressively pursuing collaborations with outsourcing partners to ramp up the production of its obesity drug, Zepbound...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Acquisition of Catalent, Inc. by Novo Holdings | Benzinga

NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities w...

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CTLT, FREE, NGM | Benzinga

NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potentia...
Next 10